TNFR2 deficiency acts in concert with gut microbiota to precipitate spontaneous sex-biased central nervous system demyelinating autoimmune disease

Journal of Immunology

Volumn 195, Issue 10, 2015, Pages 4668-4684

  Miller, Patrick G ^a   Bonn, Michael B ^a   Franklin, Craig L ^a   Ericsson, Aaron C ^a   McKarns, Susan C ^a  

^a UNIVERSITY OF MISSOURI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEATH RECEPTOR 4; DEATH RECEPTOR 5; GAMMA INTERFERON; IMMUNOGLOBULIN G2B; INTERLEUKIN 17; RNA 16S; IMMUNOGLOBULIN G; MOG PROTEIN, MOUSE; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; TUMOR NECROSIS FACTOR RECEPTOR 2;

ANAEROPLASMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; BACTEROIDES; BACTEROIDES ACIDIFACIENS; BACTEROIDES FRAGILIS; BACTEROIDES UNIFORMIS; BIFIDOBACTERIUM; CD4+ T LYMPHOCYTE; CLOSTRIDIUM; CYANOBACTERIUM; CYTOKINE PRODUCTION; DEMYELINATING DISEASE; DISEASE SEVERITY; EFFECTOR CELL; FEMALE; FIRMICUTES; GENOTYPE; GENUS; IMMUNE RESPONSE; INTESTINE FLORA; LACTOBACILLUS; MALE; MOLLICUTES; MOUSE; NONHUMAN; OLIGODENDROGLIA; PARABACTEROIDES; POPULATION ABUNDANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SEX DIFFERENCE; T LYMPHOCYTE; VERRUCOMICROBIA; ANIMAL; BACTERIUM; BIOSYNTHESIS; C57BL MOUSE; CYTOLOGY; GENETICS; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; KNOCKOUT MOUSE; MICROBIOLOGY; REGULATORY T LYMPHOCYTE; TH17 CELL;

ANIMALS; BACTERIA; DEMYELINATING AUTOIMMUNE DISEASES, CNS; FEMALE; GASTROINTESTINAL MICROBIOME; IMMUNOGLOBULIN G; INTERFERON-GAMMA; INTERLEUKIN-17; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELIN-OLIGODENDROCYTE GLYCOPROTEIN; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; RNA, RIBOSOMAL, 16S; SEX FACTORS; T-LYMPHOCYTES, REGULATORY; TH17 CELLS;

EID: 84958636544     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1501664     Document Type: Article

References (105)

1. Selmaj, K., C. S. Raine, B. Cannella, and C. F. Brosnan. 1991. Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J. Clin. Invest. 87: 949-954.
2. Begolka, W. S., C. L. Vanderlugt, S. M. Rahbe, and S. D. Miller. 1998. Differential expression of inflammatory cytokines parallels progression of central nervous system pathology in two clinically distinct models of multiple sclerosis. J. Immunol. 161: 4437-4446.
3. Powell, M. B., D. Mitchell, J. Lederman, J. Buckmeier, S. S. Zamvil, M. Graham, N. H. Ruddle, and L. Steinman. 1990. Lymphotoxin and tumor necrosis factor-alpha production by myelin basic protein-specific T cell clones correlates with encephalitogenicity. Int. Immunol. 2: 539-544.
4. The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group. 1999. TNF neutralization in MS: results of a randomized, placebo-controlled multicenter study. Neurology 53: 457-465.
5. Feldmann, M., and L. Steinman. 2005. Design of effective immunotherapy for human autoimmunity. Nature 435: 612-619.
6. Blakemore, W. F., and K. A. Irvine. 2008. Endogenous or exogenous oligodendrocytes for remyelination. J. Neurol. Sci. 265: 43-46.
7. Wingerchuk, D. M. 2006. Neuromyelitis optica. Int. MS J. 13: 42-50.
8. Bettelli, E., T. Korn, M. Oukka, and V. K. Kuchroo. 2008. Induction and effector functions of TH17 cells. Nature 453: 1051-1057.
9. Lovett-Racke, A. E., Y. Yang, and M. K. Racke. 2011. Th1 versus Th17: are T cell cytokines relevant in multiple sclerosis? Biochim. Biophys. Acta 1812: 246-251.
10. Hjelmström, P., A. E. Juedes, J. Fjell, and N. H. Ruddle. 1998. B-cell-deficient mice develop experimental allergic encephalomyelitis with demyelination after myelin oligodendrocyte glycoprotein sensitization. J. Immunol. 161: 4480-4483.
11. Lyons, J. A., M. San, M. P. Happ, and A. H. Cross. 1999. B cells are critical to induction of experimental allergic encephalomyelitis by protein but not by a short encephalitogenic peptide. Eur. J. Immunol. 29: 3432-3439.
12. Oliver, A. R., G. M. Lyon, and N. H. Ruddle. 2003. Rat and human myelin oligodendrocyte glycoproteins induce experimental autoimmune encephalomyelitis by different mechanisms in C57BL/6 mice. J. Immunol. 171: 462-468.
13. Jarius, S., F. Paul, D. Franciotta, P. Waters, F. Zipp, R. Hohlfeld, A. Vincent, and B. Wildemann. 2008. Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica. Nat. Clin. Pract. Neurol. 4: 202-214.
14. Varrin-Doyer, M., C. M. Spencer, U. Schulze-Topphoff, P. A. Nelson, R. M. Stroud, B. A. Cree, and S. S. Zamvil. 2012. Aquaporin 4-specific T cells in neuromyelitis optica exhibit a Th17 bias and recognize Clostridium ABC transporter. Ann. Neurol. 72: 53-64.
15. Jones, M. V., H. Huang, P. A. Calabresi, and M. Levy. 2015. Pathogenic aquaporin-4 reactive T cells are sufficient to induce mouse model of neuromyelitis optica. Acta Neuropathol. Commun. 3: 28.
16. Vandenabeele, P., W. Declercq, R. Beyaert, and W. Fiers. 1995. Two tumour necrosis factor receptors: structure and function. Trends Cell Biol. 5: 392-399.
17. Vinay, D. S., and B. S. Kwon. 2011. The tumour necrosis factor/TNF receptor superfamily: therapeutic targets in autoimmune diseases. Clin. Exp. Immunol. 164: 145-157.
18. Faustman, D., and M. Davis. 2010. TNF receptor 2 pathway: drug target for autoimmune diseases. Nat. Rev. Drug Discov. 9: 482-493.
19. Chen, X., M. Bäumel, D. N. Männel, O. M. Howard, and J. J. Oppenheim. 2007. Interaction of TNF with TNF receptor type 2 promotes expansion and function of mouse CD4+CD25+ T regulatory cells. J. Immunol. 179: 154-161.
20. Chen, X., J. J. Subleski, R. Hamano, O. M. Howard, R. H. Wiltrout, and J. J. Oppenheim. 2010. Co-expression of TNFR2 and CD25 identifies more of the functional CD4+FOXP3+ regulatory T cells in human peripheral blood. Eur. J. Immunol. 40: 1099-1106.
21. Gregory, A. P., C. A. Dendrou, K. E. Attfield, A. Haghikia, D. K. Xifara, F. Butter, G. Poschmann, G. Kaur, L. Lambert, O. A. Leach, et al. 2012. TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis. Nature 488: 508-511.
22. Eugster, H. P., K. Frei, R. Bachmann, H. Bluethmann, H. Lassmann, and A. Fontana. 1999. Severity of symptoms and demyelination in MOG-induced EAE depends on TNFR1. Eur. J. Immunol. 29: 626-632.
23. Evangelidou, M.,M. Karamita, S. S. Vamvakas, D. E. Szymkowski, and L. Probert. 2014. Altered expression of oligodendrocyte and neuronal marker genes predicts the clinical onset of autoimmune encephalomyelitis and indicates the effectiveness of multiple sclerosis-directed therapeutics. J. Immunol. 192: 4122-4133.
24. Kohm, A. P., P. A. Carpentier, H. A. Anger, and S. D. Miller. 2002. Cutting edge: CD4+CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis. J. Immunol. 169: 4712-4716.
25. Zhang, X., D. N. Koldzic, L. Izikson, J. Reddy, R. F. Nazareno, S. Sakaguchi, V. K. Kuchroo, and H. L. Weiner. 2004. IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25+CD4+ regulatory T cells. Int. Immunol. 16: 249-256.
26. McGeachy, M. J., L. A. Stephens, and S. M. Anderton. 2005. Natural recovery and protection from autoimmune encephalomyelitis: contribution of CD4+CD25+ regulatory cells within the central nervous system. J. Immunol. 175: 3025-3032.
27. Hyttinen, V., J. Kaprio, L. Kinnunen, M. Koskenvuo, and J. Tuomilehto. 2003. Genetic liability of type 1 diabetes and the onset age among 22,650 young Finnish twin pairs: a nationwide follow-up study. Diabetes 52: 1052-1055.
28. Gaboriau-Routhiau, V., S. Rakotobe, E. Lécuyer, I. Mulder, A. Lan, C. Bridonneau, V. Rochet, A. Pisi, M. De Paepe, G. Brandi, et al. 2009. The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity 31: 677-689.
29. Lee, Y. K., J. S. Menezes, Y. Umesaki, and S. K. Mazmanian. 2011. Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. USA 108(Suppl. 1): 4615-4622.
30. Berer, K., M. Mues, M. Koutrolos, Z. A. Rasbi, M. Boziki, C. Johner, H. Wekerle, and G. Krishnamoorthy. 2011. Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. Nature 479: 538-541.
31. Müller, U., C. V. Jongeneel, S. A. Nedospasov, K. F. Lindahl, and M. Steinmetz. 1987. Tumour necrosis factor and lymphotoxin genes map close to H-2D in the mouse major histocompatibility complex. Nature 325: 265-267.
32. Bettelli, E., M. Pagany, H. L. Weiner, C. Linington, R. A. Sobel, and V. K. Kuchroo. 2003. Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis. J. Exp. Med. 197: 1073-1081.
33. Bettelli, E., D. Baeten, A. Jäger, R. A. Sobel, and V. K. Kuchroo. 2006. Myelin oligodendrocyte glycoprotein-specific T and B cells cooperate to induce a Devic-like disease in mice. J. Clin. Invest. 116: 2393-2402.
34. Bailey, S. L., B. Schreiner, E. J. McMahon, and S. D. Miller. 2007. CNS myeloid DCs presenting endogenous myelin peptides "preferentially" polarize CD4+ TH-17 cells in relapsing EAE. Nat. Immunol. 8: 172-180.
35. Yu, Z., and M. Morrison. 2004. Improved extraction of PCR-quality community DNA from digesta and fecal samples. Biotechniques 36: 808-812.
36. Caporaso, J. G., C. L. Lauber, W. A. Walters, D. Berg-Lyons, C. A. Lozupone, P. J. Turnbaugh, N. Fierer, and R. Knight. 2011. Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample. Proc. Natl. Acad. Sci. USA 108(Suppl. 1): 4516-4522.
37. Walters, W. A., J. G. Caporaso, C. L. Lauber, D. Berg-Lyons, N. Fierer, and R. Knight. 2011. PrimerProspector: de novo design and taxonomic analysis of barcoded polymerase chain reaction primers. Bioinformatics 27: 1159-1161.
38. Loy, A., F. Maixner, M. Wagner, and M. Horn. 2007. probeBase-an online resource for rRNA-targeted oligonucleotide probes: new features 2007. Nucleic Acids Res. 35: D800-D804.
39. Magoc, T., and S. L. Salzberg. 2011. FLASH: fast length adjustment of short reads to improve genome assemblies. Bioinformatics 27: 2957-2963.
40. Kuczynski, J., J. Stombaugh, W. A. Walters, A. Gonzalez, J. G. Caporaso, and R. Knight. 2011. Using QIIME to analyze 16S rRNA gene sequences from microbial communities. Curr. Protoc. Bioinformatics Chapter 10: Unit 10.17. doi:10.1002/0471250953.bi1007s36
41. Altschul, S. F., T. L. Madden, A. A. Schäffer, J. Zhang, Z. Zhang, W. Miller, and D. J. Lipman. 1997. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 25: 3389-3402.
42. DeSantis, T. Z., P. Hugenholtz, N. Larsen, M. Rojas, E. L. Brodie, K. Keller, T. Huber, D. Dalevi, P. Hu, and G. L. Andersen. 2006. Greengenes, a chimerachecked 16S rRNA gene database and workbench compatible with ARB. Appl. Environ. Microbiol. 72: 5069-5072.
43. Miller, P. G., M. B. Bonn, and S. C. McKarns. 2015. Transmembrane TNFTNFR2 impairs Th17 differentiation by promoting Il2 expression. J. Immunol. 195: 2633-2647.
44. Suvannavejh, G. C., H. O. Lee, J. Padilla, M. C. Dal Canto, T. A. Barrett, and S. D. Miller. 2000. Divergent roles for p55 and p75 tumor necrosis factor receptors in the pathogenesis of MOG35-55-induced experimental autoimmune encephalomyelitis. Cell. Immunol. 205: 24-33.
45. Kassiotis, G., and G. Kollias. 2001. Uncoupling the proinflammatory from the immunosuppressive properties of tumor necrosis factor (TNF) at the p55 TNF receptor level: implications for pathogenesis and therapy of autoimmune demyelination. J. Exp. Med. 193: 427-434.
46. Williams, S. K., O. Maier, R. Fischer, R. Fairless, S. Hochmeister, A. Stojic, L. Pick, D. Haar, S. Musiol, M. K. Storch, et al. 2014. Antibody-mediated inhibition of TNFR1 attenuates disease in a mouse model of multiple sclerosis. PLoS One 9: e90117.
47. Krishnamoorthy, G., H. Lassmann, H. Wekerle, and A. Holz. 2006. Spontaneous opticospinal encephalomyelitis in a double-transgenic mouse model of autoimmune T cell/B cell cooperation. J. Clin. Invest. 116: 2385-2392.
48. McKarns, S. C., and R. H. Schwartz. 2008. Biphasic regulation of Il2 transcription in CD4+ T cells: roles for TNF-α receptor signaling and chromatin structure. J. Immunol. 181: 1272-1281.
49. Berger, T., S. Weerth, K. Kojima, C. Linington, H. Wekerle, and H. Lassmann. 1997. Experimental autoimmune encephalomyelitis: the antigen specificity of T lymphocytes determines the topography of lesions in the central and peripheral nervous system. Lab. Invest. 76: 355-364.
50. O'Riordan, J. I., H. L. Gallagher, A. J. Thompson, R. S. Howard, D. P. Kingsley, E. J. Thompson, W. I. McDonald, and D. H. Miller. 1996. Clinical, CSF, and MRI findings in Devic's neuromyelitis optica. J. Neurol. Neurosurg. Psychiatry 60: 382-387.
51. Reading, N. C., and D. L. Kasper. 2011. The starting lineup: key microbial players in intestinal immunity and homeostasis. Front. Microbiol. 2: 148.
52. Robinson, W. H., M. C. Genovese, and L. W. Moreland. 2001. Demyelinating and neurologic events reported in association with tumor necrosis factor alpha antagonism: by what mechanisms could tumor necrosis factor alpha antagonists improve rheumatoid arthritis but exacerbate multiple sclerosis? Arthritis Rheum. 44: 1977-1983.
53. Sotgiu, S., M. Pugliatti, M. L. Fois, G. Arru, A. Sanna, M. A. Sotgiu, and G. Rosati. 2004. Genes, environment, and susceptibility to multiple sclerosis. Neurobiol. Dis. 17: 131-143.
54. Rovira, A., J. Swanton, M. Tintoré, E. Huerga, F. Barkhof, M. Filippi, J. L. Frederiksen, A. Langkilde, K. Miszkiel, C. Polman, et al. 2009. A single, early magnetic resonance imaging study in the diagnosis of multiple sclerosis. Arch. Neurol. 66: 587-592.
55. Oh, J., and M. Levy. 2012. Neuromyelitis optica: an antibody-mediated disorder of the central nervous system. Neurol. Res. Int. 2012: 460825.
56. Rubtsova, K., P. Marrack, and A. V. Rubtsov. 2015. Sexual dimorphism in autoimmunity. J. Clin. Invest. 125: 2187-2193.
57. Cruz-Orengo, L., B. P. Daniels, D. Dorsey, S. A. Basak, J. G. Grajales-Reyes, E. E. McCandless, L. Piccio, R. E. Schmidt, A. H. Cross, S. D. Crosby, and R. S. Klein. 2014. Enhanced sphingosine-1-phosphate receptor 2 expression underlies female CNS autoimmunity susceptibility. J. Clin. Invest. 124: 2571-2584.
58. Burek, M., P. A. Arias-Loza, N. Roewer, and C. Y. Förster. 2010. Claudin-5 as a novel estrogen target in vascular endothelium. Arterioscler. Thromb. Vasc. Biol. 30: 298-304.
59. Becker, K. G., R. M. Simon, J. E. Bailey-Wilson, B. Freidlin, W. E. Biddison, H. F. McFarland, and J. M. Trent. 1998. Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases. Proc. Natl. Acad. Sci. USA 95: 9979-9984.
60. Brodin, P., V. Jojic, T. Gao, S. Bhattacharya, C. J. Angel, D. Furman, S. Shen-Orr, C. L. Dekker, G. E. Swan, A. J. Butte, et al. 2015. Variation in the human immune system is largely driven by non-heritable influences. Cell 160: 37-47.
61. Pöllinger, B., G. Krishnamoorthy, K. Berer, H. Lassmann, M. R. Bösl, R. Dunn, H. S. Domingues, A. Holz, F. C. Kurschus, and H. Wekerle. 2009. Spontaneous relapsing-remitting EAE in the SJL/J mouse: MOG-reactive transgenic T cells recruit endogenous MOG-specific B cells. J. Exp. Med. 206: 1303-1316.
62. Markle, J. G., D. N. Frank, S. Mortin-Toth, C. E. Robertson, L. M. Feazel, U. Rolle-Kampczyk, M. von Bergen, K. D. McCoy, A. J. Macpherson, and J. S. Danska. 2013. Sex differences in the gut microbiome drive hormonedependent regulation of autoimmunity. Science 339: 1084-1088.
63. Yurkovetskiy, L., M. Burrows, A. A. Khan, L. Graham, P. Volchkov, L. Becker, D. Antonopoulos, Y. Umesaki, and A. V. Chervonsky. 2013. Gender bias in autoimmunity is influenced by microbiota. Immunity 39: 400-412.
64. Cohen, J. I. 2000. Epstein-Barr virus infection. N. Engl. J. Med. 343: 481-492.
65. Thacker, E. L., F. Mirzaei, and A. Ascherio. 2006. Infectious mononucleosis and risk for multiple sclerosis: a meta-analysis. Ann. Neurol. 59: 499-503.
66. Westall, F. C. 2006. Molecular mimicry revisited: gut bacteria and multiple sclerosis. J. Clin. Microbiol. 44: 2099-2104.
67. Berer, K., and G. Krishnamoorthy. 2012. Commensal gut flora and brain autoimmunity: a love or hate affair? Acta Neuropathol. 123: 639-651.
68. Mazmanian, S. K., C. H. Liu, A. O. Tzianabos, and D. L. Kasper. 2005. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 122: 107-118.
69. Wang, Y., K. M. Telesford, J. Ochoa-Repáraz, S. Haque-Begum, M. Christy, E. J. Kasper, L. Wang, Y. Wu, S. C. Robson, D. L. Kasper, and L. H. Kasper. 2014. An intestinal commensal symbiosis factor controls neuroinflammation via TLR2-mediated CD39 signalling. Nat. Commun. 5: 4432.
70. Ochoa-Repáraz, J., D. W. Mielcarz, S. Haque-Begum, and L. H. Kasper. 2010. Induction of a regulatory B cell population in experimental allergic encephalomyelitis by alteration of the gut commensal microflora. Gut Microbes 1: 103-108.
71. Ezendam, J., A. de Klerk, E. R. Gremmer, and H. van Loveren. 2008. Effects of Bifidobacterium animalis administered during lactation on allergic and autoimmune responses in rodents. Clin. Exp. Immunol. 154: 424-431.
72. Lavasani, S., B. Dzhambazov, M. Nouri, F. Faik, S. Buske, G. Molin, H. Thorlacius, J. Alenfall, B. Jeppsson, and B. Weström. 2010. A novel probiotic mixture exerts a therapeutic effect on experimental autoimmune encephalomyelitis mediated by IL-10 producing regulatory T cells. PLoS One 5: e9009.
73. Cantarel, B. L., E. Waubant, C. Chehoud, J. Kuczynski, T. Z. DeSantis, J. Warrington, A. Venkatesan, C. M. Fraser, and E. M. Mowry. 2015. Gut microbiota in multiple sclerosis: possible influence of immunomodulators. J. Investig. Med. 63: 729-734.
74. Thorkildsen, L. T., F. C. Nwosu, E. Avershina, P. Ricanek, G. Perminow, S. Brackmann, M. H. Vatn, and K. Rudi. 2013. Dominant fecal microbiota in newly diagnosed untreated inflammatory bowel disease patients. Gastroenterol. Res. Pract. 2013: 636785.
75. Carlsson, A. H., O. Yakymenko, I. Olivier, F. Hakansson, E. Postma, A. V. Keita, and J. D. Söderholm. 2013. Faecalibacterium prausnitzii supernatant improves intestinal barrier function in mice DSS colitis. Scand. J. Gastroenterol. 48: 1136-1144.
76. Kitley, J., P. Waters, M. Woodhall, M. I. Leite, A. Murchison, J. George, W. Küker, S. Chandratre, A. Vincent, and J. Palace. 2014. Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study. JAMA Neurol. 71: 276-283.
77. Derrien, M., P. Van Baarlen, G. Hooiveld, E. Norin, M. Müller, and W. M. de Vos. 2011. Modulation of mucosal immune response, tolerance, and proliferation in mice colonized by the mucin-degrader Akkermansia muciniphila. Front. Microbiol. 2: 166.
78. Lukovac, S., C. Belzer, L. Pellis, B. J. Keijser,W. M. de Vos, R. C. Montijn, and G. Roeselers. 2014. Differential modulation by Akkermansia muciniphila and Faecalibacterium prausnitzii of host peripheral lipid metabolism and histone acetylation in mouse gut organoids. MBio 5: 5.
79. Cipolletta, D., M. Feuerer, A. Li, N. Kamei, J. Lee, S. E. Shoelson, C. Benoist, and D. Mathis. 2012. PPAR-g is a major driver of the accumulation and phenotype of adipose tissue Treg cells. Nature 486: 549-553.
80. Hansen, C. H., L. Krych, D. S. Nielsen, F. K. Vogensen, L. H. Hansen, S. J. Serensen, K. Buschard, and A. K. Hansen. 2012. Early life treatment with vancomycin propagates Akkermansia muciniphila and reduces diabetes incidence in the NOD mouse. Diabetologia 55: 2285-2294.
81. Zhang, X., D. Shen, Z. Fang, Z. Jie, X. Qiu, C. Zhang, Y. Chen, and L. Ji. 2013. Human gut microbiota changes reveal the progression of glucose intolerance. PLoS One 8: e71108.
82. Everard, A., C. Belzer, L. Geurts, J. P. Ouwerkerk, C. Druart, L. B. Bindels, Y. Guiot, M. Derrien, G. G. Muccioli, N. M. Delzenne, et al. 2013. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls dietinduced obesity. Proc. Natl. Acad. Sci. USA 110: 9066-9071.
83. De Angelis, M., M. Piccolo, L. Vannini, S. Siragusa, A. De Giacomo, D. I. Serrazzanetti, F. Cristofori, M. E. Guerzoni, M. Gobbetti, and R. Francavilla. 2013. Fecal microbiota and metabolome of children with autism and pervasive developmental disorder not otherwise specified. PLoS One 8: e76993.
84. Biagi, E., M. Candela, M. Centanni, C. Consolandi, S. Rampelli, S. Turroni, M. Severgnini, C. Peano, A. Ghezzo, M. Scurti, et al. 2014. Gut microbiome in Down syndrome. PLoS One 9: e112023.
85. Moon, C., M. T. Baldridge, M. A. Wallace, C. A. Burnham, H. W. Virgin, and T. S. Stappenbeck. 2015. Vertically transmitted faecal IgA levels determine extra-chromosomal phenotypic variation. Nature 521: 90-93.
86. Mantis, N. J., N. Rol, and B. Corthésy. 2011. Secretory IgA's complex roles in immunity and mucosal homeostasis in the gut. Mucosal Immunol. 4: 603-611.
87. Fujimoto, T., H. Imaeda, K. Takahashi, E. Kasumi, S. Bamba, Y. Fujiyama, and A. Andoh. 2013. Decreased abundance of Faecalibacterium prausnitzii in the gut microbiota of Crohn's disease. J. Gastroenterol. Hepatol. 28: 613-619.
88. Brahe, L. K., E. Le Chatelier, E. Prifti, N. Pons, S. Kennedy, T. Hansen, O. Pedersen, A. Astrup, S. D. Ehrlich, and L. H. Larsen. 2015. Specific gut microbiota features and metabolic markers in postmenopausal women with obesity. Nutr. Diabetes 5: e159.
89. Ercolini, A. M., and S. D. Miller. 2007. Molecular mimics can induce novel self peptide-reactive CD4+ T cell clonotypes in autoimmune disease. J. Immunol. 179: 6604-6612.
90. de Vos, A. F., M. van Meurs, H. P. Brok, L. A. Boven, R. Q. Hintzen, P. van der Valk, R. Ravid, S. Rensing, L. Boon, B. A. 't Hart, and J. D. Laman. 2002. Transfer of central nervous system autoantigens and presentation in secondary lymphoid organs. J. Immunol. 169: 5415-5423.
91. Round, J. L., and S. K. Mazmanian. 2010. Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc. Natl. Acad. Sci. USA 107: 12204-12209.
92. Mohamadzadeh, M., and T. R. Klaenhammer. 2008. Specific Lactobacillus species differentially activate Toll-like receptors and downstream signals in dendritic cells. Expert Rev. Vaccines 7: 1155-1164.
93. Shulzhenko, N., A. Morgun, W. Hsiao, M. Battle, M. Yao, O. Gavrilova, M. Orandle, L. Mayer, A. J. Macpherson, K. D. McCoy, et al. 2011. Crosstalk between B lymphocytes, microbiota and the intestinal epithelium governs immunity versus metabolism in the gut. Nat. Med. 17: 1585-1593.
94. Fox, H. S., B. L. Bond, and T. G. Parslow. 1991. Estrogen regulates the IFNgamma promoter. J. Immunol. 146: 4362-4367.
95. Johnson-Léger, C., J. Hasbold, M. Holman, and G. G. Klaus. 1997. The effects of IFN-g on CD40-mediated activation of B cells from X-linked immunodeficient or normal mice. J. Immunol. 159: 1150-1159.
96. Finkelman, F. D., J. Holmes, I. M. Katona, J. F. Urban, Jr., M. P. Beckmann, L. S. Park, K. A. Schooley, R. L. Coffman, T. R. Mosmann, and W. E. Paul. 1990. Lymphokine control of in vivo immunoglobulin isotype selection. Annu. Rev. Immunol. 8: 303-333.
97. Ito, A., B. F. Bebo, Jr., A. Matejuk, A. Zamora, M. Silverman, A. Fyfe-Johnson, and H. Offner. 2001. Estrogen treatment down-regulates TNF-α production and reduces the severity of experimental autoimmune encephalomyelitis in cytokine knockout mice. J. Immunol. 167: 542-552.
98. Jawaheer, D., J. Olsen, and M. L. Hetland. 2012. Sex differences in response to anti-tumor necrosis factor therapy in early and established rheumatoid arthritis -results from the DANBIO registry. J. Rheumatol. 39: 46-53.
99. Saevarsdottir, S., H. Wallin, M. Seddighzadeh, S. Ernestam, P. Geborek, I. F. Petersson, J. Bratt, and R. F. van Vollenhoven, SWEFOT Trial Investigators Group. 2011. Predictors of response to methotrexate in early DMARD naive rheumatoid arthritis: results from the initial open-label phase of the SWEFOT trial. Ann. Rheum. Dis. 70: 469-475.
100. Mäkinen, H., P. Hannonen, and T. Sokka. 2008. Sex: a major predictor of remission as measured by 28-joint Disease Activity Score (DAS28) in early rheumatoid arthritis? Ann. Rheum. Dis. 67: 1052-1053.
101. Burmester, G. R., G. Ferraccioli, R. M. Flipo, I. Monteagudo-Sáez, K. Unnebrink, S. Kary, and H. Kupper. 2008. Clinical remission and/or minimal disease activity in patients receiving adalimumab treatment in a multinational, open-label, twelveweek study. Arthritis Rheum. 59: 32-41.
102. Wang, M., P. R. Crisostomo, T. A. Markel, Y. Wang, and D. R. Meldrum. 2008. Mechanisms of sex differences in TNFR2-mediated cardioprotection. Circulation 118(14, Suppl.): S38-S45.
103. Dayer Schneider, J., I. Seibold, N. Saxer-Sekulic, B. E. Paredes, L. Saurer, and C. Mueller. 2009. Lack of TNFR2 expression by CD4+ T cells exacerbates experimental colitis. Eur. J. Immunol. 39: 1743-1753.
104. Housley, W. J., C. O. Adams, F. C. Nichols, L. Puddington, E. G. Lingenheld, L. Zhu, T. V. Rajan, and R. B. Clark. 2011. Natural but not inducible regulatory T cells require TNF-α signaling for in vivo function. J. Immunol. 186: 6779-6787.
105. Peschon, J. J., D. S. Torrance, K. L. Stocking, M. B. Glaccum, C. Otten, C. R. Willis, K. Charrier, P. J. Morrissey, C. B. Ware, and K. M. Mohler. 1998. TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation. J. Immunol. 160: 943-952.